array(3) { ["company_details"]=> array(13) { ["name"]=> string(35) "Tekla Healthcare Opportunities Fund" ["slug"]=> string(44) "e8566-us-tekla-healthcare-opportunities-fund" ["logo"]=> NULL ["description"]=> string(983) "Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in the United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. It focuses on investing in private companies and other restricted securities, including private investments in public equity and venture capital investments, if these securities would comprise approximately 10% or less of managed assets. It invests in sub-sectors, such as biotechnology, healthcare equipment and supplies, healthcare providers and services, healthcare technology, life sciences tools and services, pharmaceuticals, real estate investment trusts, real estate management and development. Tekla Capital Management LLC is the investment advisor of the Fund." ["address_street"]=> string(17) "2 Liberty Sq FL 9" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2014-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(24) "https://www.teklacap.com" ["industry_codes"]=> array(1) { [0]=> string(53) "Trusts, Except Educational, Religious, and Charitable" } ["employee_count"]=> int(2) ["article_count"]=> int(145) } ["articles"]=> array(4) { [0]=> array(7) { ["title_en"]=> string(72) "Tekla Capital Management LLC Announces Closing of Transaction With abrdn" ["snippet_en"]=> string(300) "BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic" ["url"]=> string(101) "https://www.fintechnews.org/tekla-capital-management-llc-announces-closing-of-transaction-with-abrdn/" ["image_url"]=> NULL ["source"]=> string(15) "fintechnews.org" ["publication_date"]=> string(10) "2023-10-29" ["categories"]=> array(5) { [0]=> string(22) "Business Restructuring" [1]=> string(11) "Acquisition" [2]=> string(25) "Business Model Resilience" [3]=> string(10) "Divestment" [4]=> string(20) "Business Development" } } [1]=> array(7) { ["title_en"]=> string(72) "Tekla Capital Management LLC Announces Closing of Transaction With abrdn" ["snippet_en"]=> string(297) "Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under" ["url"]=> string(120) "https://www.nasdaq.com/press-release/tekla-capital-management-llc-announces-closing-of-transaction-with-abrdn-2023-10-27" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-06-30" ["categories"]=> array(5) { [0]=> string(22) "Business Restructuring" [1]=> string(11) "Acquisition" [2]=> string(25) "Business Model Resilience" [3]=> string(10) "Divestment" [4]=> string(20) "Business Development" } } [2]=> array(7) { ["title_en"]=> string(70) "Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc." ["snippet_en"]=> string(190) "Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds." ["url"]=> string(118) "https://www.nasdaq.com/press-release/tekla-funds-approve-new-investment-advisory-agreements-with-abrdn-inc.-2023-10-27" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-06-30" ["categories"]=> array(5) { [0]=> string(18) "General Investment" [1]=> string(15) "Deals & Tenders" [2]=> string(19) "Investment Requests" [3]=> string(13) "Collaboration" [4]=> string(25) "Business Model Resilience" } } [3]=> array(7) { ["title_en"]=> string(78) "abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM" ["snippet_en"]=> string(269) "abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts." ["url"]=> string(84) "https://finance.yahoo.com/news/abrdn-acquire-us-specialist-healthcare-221500989.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/965c9901-84c5-4864-8fbd-8c2564370b75" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-06-20" ["categories"]=> array(3) { [0]=> string(18) "General Investment" [1]=> string(25) "Business Model Resilience" [2]=> string(11) "Acquisition" } } } ["category_annotations"]=> array(25) { [0]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(29) } [1]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(10) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(7) } [3]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(4) } [4]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(4) } [6]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [7]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(3) } [8]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [9]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(18) "Business Structure" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(16) "Customer Privacy" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(11) "Slush Funds" ["count"]=> int(1) } } } e8566-us-tekla-healthcare-opportunities-fund

Tekla Healthcare Opportunities Fund

Location

Massachusetts

Founded

2014-01-26

Website

https://www.teklacap.com

Articles

145 Articles

Category

Trusts, Except Educational, Religious, and Charitable

Description

Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in the United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. It focuses on investing in private companies and other restricted securities, including private investments in public equity and venture capital investments, if these securities would comprise approximately 10% or less of managed assets. It invests in sub-sectors, such as biotechnology, healthcare equipment and supplies, healthcare providers and services, healthcare technology, life sciences tools and services, pharmaceuticals, real estate investment trusts, real estate management and development. Tekla Capital Management LLC is the investment advisor of the Fund.

Articles

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

2023-10-29 (fintechnews.org)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

BOSTON–(BUSINESS WIRE)–HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic

Read more
Tekla Capital Management LLC Announces Closing of Transaction With abrdn

2023-06-30 (nasdaq.com)

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under

Read more
Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.

2023-06-30 (nasdaq.com)

Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.

Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds.

Read more
abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM

2023-06-20 (yahoo.com)

abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM

abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts.

Read more

Newsletter subscription